The global Pembrolizumab market size was valued at US$ 15.67 billion in 2024 and is projected to reach US$ 27.91 billion by 2030, at a CAGR of 10.1% during the forecast period 2024-2030.
United States Pembrolizumab market size was valued at US$ 5.12 billion in 2024 and is projected to reach US$ 8.75 billion by 2030, at a CAGR of 9.4% during the forecast period 2024-2030.
Strong growth supported by broad range of approved indications across multiple cancer types. Leading position in first-line lung cancer treatment. Continued expansion into new indications and earlier lines of therapy.
Report Overview
This report provides a deep insight into the global Pembrolizumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pembrolizumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pembrolizumab market in any manner.
Global Pembrolizumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Market Segmentation (by Type)
- 50mg Injection
- 100mg Injection
Market Segmentation (by Application)
- Advanced Melanoma
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Unresectable or Metastatic Solid Tumor
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pembrolizumab Market
- Overview of the regional outlook of the Pembrolizumab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pembrolizumab
1.2 Key Market Segments
1.2.1 Pembrolizumab Segment by Type
1.2.2 Pembrolizumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pembrolizumab Market Overview
2.1 Global Market Overview
2.1.1 Global Pembrolizumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pembrolizumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pembrolizumab Market Competitive Landscape
3.1 Global Pembrolizumab Sales by Manufacturers (2019-2024)
3.2 Global Pembrolizumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Pembrolizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pembrolizumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pembrolizumab Sales Sites, Area Served, Product Type
3.6 Pembrolizumab Market Competitive Situation and Trends
3.6.1 Pembrolizumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pembrolizumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pembrolizumab Industry Chain Analysis
4.1 Pembrolizumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pembrolizumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pembrolizumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pembrolizumab Sales Market Share by Type (2019-2024)
6.3 Global Pembrolizumab Market Size Market Share by Type (2019-2024)
6.4 Global Pembrolizumab Price by Type (2019-2024)
7 Pembrolizumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pembrolizumab Market Sales by Application (2019-2024)
7.3 Global Pembrolizumab Market Size (M USD) by Application (2019-2024)
7.4 Global Pembrolizumab Sales Growth Rate by Application (2019-2024)
8 Pembrolizumab Market Segmentation by Region
8.1 Global Pembrolizumab Sales by Region
8.1.1 Global Pembrolizumab Sales by Region
8.1.2 Global Pembrolizumab Sales Market Share by Region
8.2 North America
8.2.1 North America Pembrolizumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pembrolizumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pembrolizumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pembrolizumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pembrolizumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Pembrolizumab Basic Information
9.1.2 Merck Pembrolizumab Product Overview
9.1.3 Merck Pembrolizumab Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Pembrolizumab SWOT Analysis
9.1.6 Merck Recent Developments
10 Pembrolizumab Market Forecast by Region
10.1 Global Pembrolizumab Market Size Forecast
10.2 Global Pembrolizumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pembrolizumab Market Size Forecast by Country
10.2.3 Asia Pacific Pembrolizumab Market Size Forecast by Region
10.2.4 South America Pembrolizumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pembrolizumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pembrolizumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pembrolizumab by Type (2025-2030)
11.1.2 Global Pembrolizumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pembrolizumab by Type (2025-2030)
11.2 Global Pembrolizumab Market Forecast by Application (2025-2030)
11.2.1 Global Pembrolizumab Sales (Kilotons) Forecast by Application
11.2.2 Global Pembrolizumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pembrolizumab Market Size Comparison by Region (M USD)
Table 5. Global Pembrolizumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pembrolizumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pembrolizumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pembrolizumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pembrolizumab as of 2022)
Table 10. Global Market Pembrolizumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pembrolizumab Sales Sites and Area Served
Table 12. Manufacturers Pembrolizumab Product Type
Table 13. Global Pembrolizumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pembrolizumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pembrolizumab Market Challenges
Table 22. Global Pembrolizumab Sales by Type (Kilotons)
Table 23. Global Pembrolizumab Market Size by Type (M USD)
Table 24. Global Pembrolizumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pembrolizumab Sales Market Share by Type (2019-2024)
Table 26. Global Pembrolizumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Pembrolizumab Market Size Share by Type (2019-2024)
Table 28. Global Pembrolizumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pembrolizumab Sales (Kilotons) by Application
Table 30. Global Pembrolizumab Market Size by Application
Table 31. Global Pembrolizumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pembrolizumab Sales Market Share by Application (2019-2024)
Table 33. Global Pembrolizumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Pembrolizumab Market Share by Application (2019-2024)
Table 35. Global Pembrolizumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Pembrolizumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pembrolizumab Sales Market Share by Region (2019-2024)
Table 38. North America Pembrolizumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pembrolizumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pembrolizumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pembrolizumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pembrolizumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Pembrolizumab Basic Information
Table 44. Merck Pembrolizumab Product Overview
Table 45. Merck Pembrolizumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Pembrolizumab SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Global Pembrolizumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Pembrolizumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Pembrolizumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Pembrolizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Pembrolizumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Pembrolizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Pembrolizumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Pembrolizumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Pembrolizumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Pembrolizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Pembrolizumab Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Pembrolizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Pembrolizumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Pembrolizumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Pembrolizumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Pembrolizumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Pembrolizumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pembrolizumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pembrolizumab Market Size (M USD), 2019-2030
Figure 5. Global Pembrolizumab Market Size (M USD) (2019-2030)
Figure 6. Global Pembrolizumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pembrolizumab Market Size by Country (M USD)
Figure 11. Pembrolizumab Sales Share by Manufacturers in 2023
Figure 12. Global Pembrolizumab Revenue Share by Manufacturers in 2023
Figure 13. Pembrolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pembrolizumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pembrolizumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pembrolizumab Market Share by Type
Figure 18. Sales Market Share of Pembrolizumab by Type (2019-2024)
Figure 19. Sales Market Share of Pembrolizumab by Type in 2023
Figure 20. Market Size Share of Pembrolizumab by Type (2019-2024)
Figure 21. Market Size Market Share of Pembrolizumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pembrolizumab Market Share by Application
Figure 24. Global Pembrolizumab Sales Market Share by Application (2019-2024)
Figure 25. Global Pembrolizumab Sales Market Share by Application in 2023
Figure 26. Global Pembrolizumab Market Share by Application (2019-2024)
Figure 27. Global Pembrolizumab Market Share by Application in 2023
Figure 28. Global Pembrolizumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pembrolizumab Sales Market Share by Region (2019-2024)
Figure 30. North America Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pembrolizumab Sales Market Share by Country in 2023
Figure 32. U.S. Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pembrolizumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pembrolizumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pembrolizumab Sales Market Share by Country in 2023
Figure 37. Germany Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pembrolizumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pembrolizumab Sales Market Share by Region in 2023
Figure 44. China Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pembrolizumab Sales and Growth Rate (Kilotons)
Figure 50. South America Pembrolizumab Sales Market Share by Country in 2023
Figure 51. Brazil Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pembrolizumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pembrolizumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pembrolizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pembrolizumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pembrolizumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pembrolizumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pembrolizumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Pembrolizumab Sales Forecast by Application (2025-2030)
Figure 66. Global Pembrolizumab Market Share Forecast by Application (2025-2030)
